| Raghava Reddy Induru, MD | |
|
945 N 5th St, Albemarle, NC 28001-3417 | |
| (980) 323-7790 | |
| Not Available |
| Full Name | Raghava Reddy Induru |
|---|---|
| Gender | Male |
| Speciality | Medical Oncology |
| Experience | 23 Years |
| Location | 945 N 5th St, Albemarle, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063608388 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Carolinas Medical Center/behav Health | Charlotte, NC | Hospital |
| Stanly Regional Medical Center | Albemarle, NC | Hospital |
| Carolinas Medical Center-northeast | Concord, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Charlotte-mecklenburg Hospital Authority | 2961310685 | 488 |
News Archive
Discovering the different genes that contribute to a complex disease is like searching in the proverbial haystack for an unknown number of needles-some much smaller than others, often blending into the background, and many of them widely separated from each other.
In related discoveries with far-reaching implications for treating diabetes and understanding hypertension, University of Utah researchers have learned why thiazolidinediones (TZDs), a major anti-diabetes drug, cause edema and also have found a new pathway critical to fluid metabolism. Identification of this pathway may help understand fundamental mechanisms of blood pressure control.
The New York Times: "Republicans captured control of the House of Representatives on Tuesday and expanded their voice in the Senate, riding a wave of voter discontent as they dealt a setback to President Obama just two years after his triumphal victory. A Republican resurgence, propelled by deep economic worries and a forceful opposition to the Democratic agenda of health care and government spending, delivered defeats to House Democrats from the Northeast to the South and across the Midwest" (Zeleny, 11/2).
Ariel Pharmaceuticals, Inc., a private, specialty pharmaceutical company focused on the development and commercialization of products for acute central nervous system (CNS) diseases and trauma, announced today that it has in-licensed its lead product, AP-1531, for the treatment of acute migraine attacks, from the specialist healthcare company BTG International Ltd.
› Verified 6 days ago
| Entity Name | The Charlotte-mecklenburg Hospital Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669738829 PECOS PAC ID: 2961310685 Enrollment ID: O20100309000605 |
News Archive
Discovering the different genes that contribute to a complex disease is like searching in the proverbial haystack for an unknown number of needles-some much smaller than others, often blending into the background, and many of them widely separated from each other.
In related discoveries with far-reaching implications for treating diabetes and understanding hypertension, University of Utah researchers have learned why thiazolidinediones (TZDs), a major anti-diabetes drug, cause edema and also have found a new pathway critical to fluid metabolism. Identification of this pathway may help understand fundamental mechanisms of blood pressure control.
The New York Times: "Republicans captured control of the House of Representatives on Tuesday and expanded their voice in the Senate, riding a wave of voter discontent as they dealt a setback to President Obama just two years after his triumphal victory. A Republican resurgence, propelled by deep economic worries and a forceful opposition to the Democratic agenda of health care and government spending, delivered defeats to House Democrats from the Northeast to the South and across the Midwest" (Zeleny, 11/2).
Ariel Pharmaceuticals, Inc., a private, specialty pharmaceutical company focused on the development and commercialization of products for acute central nervous system (CNS) diseases and trauma, announced today that it has in-licensed its lead product, AP-1531, for the treatment of acute migraine attacks, from the specialist healthcare company BTG International Ltd.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Raghava Reddy Induru, MD Po Box 19305, Charlotte, NC 28219-9305 Ph: () - | Raghava Reddy Induru, MD 945 N 5th St, Albemarle, NC 28001-3417 Ph: (980) 323-7790 |
News Archive
Discovering the different genes that contribute to a complex disease is like searching in the proverbial haystack for an unknown number of needles-some much smaller than others, often blending into the background, and many of them widely separated from each other.
In related discoveries with far-reaching implications for treating diabetes and understanding hypertension, University of Utah researchers have learned why thiazolidinediones (TZDs), a major anti-diabetes drug, cause edema and also have found a new pathway critical to fluid metabolism. Identification of this pathway may help understand fundamental mechanisms of blood pressure control.
The New York Times: "Republicans captured control of the House of Representatives on Tuesday and expanded their voice in the Senate, riding a wave of voter discontent as they dealt a setback to President Obama just two years after his triumphal victory. A Republican resurgence, propelled by deep economic worries and a forceful opposition to the Democratic agenda of health care and government spending, delivered defeats to House Democrats from the Northeast to the South and across the Midwest" (Zeleny, 11/2).
Ariel Pharmaceuticals, Inc., a private, specialty pharmaceutical company focused on the development and commercialization of products for acute central nervous system (CNS) diseases and trauma, announced today that it has in-licensed its lead product, AP-1531, for the treatment of acute migraine attacks, from the specialist healthcare company BTG International Ltd.
› Verified 6 days ago
Kushal C. Vaishnani, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 301 Yadkin St, Albemarle, NC 28001 Phone: 704-984-4365 | |
Douglas W Haden, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 301 Yadkin St, Albemarle, NC 28001 Phone: 704-984-4365 | |
Mr. Rufus Stamey Lefler Iii, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 923 North Second Street, Suite 101, Albemarle, NC 28001 Phone: 704-982-1136 Fax: 704-982-1139 | |
Mr. Philip Veatch, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1908 Hilco St, Suite B, Suite B, Albemarle, NC 28001 Phone: 704-983-3855 Fax: 704-985-1031 | |
Souheil Abdel Nour, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 929 N 2nd St, Ste 205, Albemarle, NC 28001 Phone: 980-323-5625 | |
Sherry J. Saxonhouse, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 307 Yadkin St, Albemarle, NC 28001 Phone: 980-323-6180 | |
Christopher Sutton Poor, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 929 N 2nd St, Ste 205, Albemarle, NC 28001 Phone: 980-323-5625 |